| 241 |
Evaluation of Fetal Cardiac Functions in Prolonged Pregnancy.
A Fetal Echocardiographic Approach
|
2009 |
| 242 |
Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre-and in-hospital abciximab pretreatment. |
2009 |
| 243 |
In‐ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: Results from the Leiden MISSION! acute myocardial infarction treatment optimiz |
2009 |
| 244 |
Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents. |
2009 |
| 245 |
SERUM CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME |
2009 |
| 246 |
The Association of PvuII Lipoprotein Lipase Gene Polymorphism with Coronary Artery Disease in Egyptians |
2009 |
| 247 |
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention |
2009 |
| 248 |
Coupled Pacing Reverses the Effects of Persistent Atrial Fibrillation on the Left Ventricle |
2008 |
| 249 |
In-ambulance abciximab administration in STEMI patients undergoing primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure |
2008 |
| 250 |
In-ambulance Abciximab Facilitated Primary PCI is Associated with Smaller Enzymatic Infarct Size, Improved LV Function and Lower Incidence of Heart Failure at One Year Clinical Follow-up |
2008 |
هل لديك سؤال ؟
